American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

January 13, 2022

Newsletter Sponsor

What’s Next for mRNA: From COVID to Cancer & Beyond.

Interest in mRNA as a therapeutic modality has exploded since the approval of mRNA-based COVID-19 vaccines. With significant data on safety and efficacy of mRNA vaccines, many companies are looking to further expand their pipelines, as well as beyond infectious disease to potentially develop therapies for a wide variety of indications. Learn more on the challenges of mRNA development and manufacturing, potential solutions and where the industry may go next with mRNA therapies.

	Industry News

Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology
Moderna Inc. and Carisma Therapeutics Inc., have entered into a strategic collaboration agreement to... read more »

Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta T Cell Engager Therapies Targeting Solid Tumors
Takeda Pharmaceutical Company Limited announced the exercise of its option to acquire Adaptate ... read more »

Novartis and Molecular Partners Report Positive Topline Data From Phase 2 Study for Ensovibep (MP0420), a DARPin Antiviral Therapeutic for COVID-19
Novartis and Molecular Partners announced that Part A of the EMPATHY clinical trial that compared ... read more »

BioNTech and Crescendo Biologics Announce Global Collaboration to Develop Multi-specific Precision Immunotherapies
BioNTech SE and Crescendo Biologics Ltd have entered a multi-target discovery collaboration to ... read more »

	Infographic

Top 5 Benefits of using MMS for QA of Biologic Drugs
Top 5 Benefits of using MMS for QA of Biologic Drugs
Learn five applications to remove risk and enable better, faster decision-making regarding the quality assurance of biologic drugs. read more »

	Featured Articles

Disinfectant Rotation and the Frequency of Use of a Sporicidal Agent Historically, the term rotation was applied to alternating the type of daily disinfectant selected. The thought was that microbes could adapt to one ... read more »

An Interview with Renee Morley, MBA Contec. Inc. is an experienced global leader in wipers, mops, and disinfectants for the pharmaceutical industry. Contec focuses on providing the ... read more »

	Featured Video

Watch Video: NewAge Facility Tour
NewAge Industries is a manufacturer and fabricator of flexible plastic tubing and hose and a supplier of fittings and clamps. We produce and stock ... watch »

Watch Video: Continuous Manufacturing Using PROSOLV®EASYtab
Continuous Manufacturing Using PROSOLV^®EASYtab watch »

	Featured Products

4Cell® Nutri-T Medium
read more »

	Featured Whitepaper

Case Study: Automation Made Easy — Efficient Integration of Devices and Software in Lab 4.0
Automation has already found its way into many areas, including the laboratory. The advantages are obvious: not only does it increase quality and productivity, but it also lowers costs and saves time.... read more »

	Events

DCAT Sharp Sourcing
Online – 01/26/2022
This 90-minute webinar brings together a panel of industry experts to offer valuable and practical insights into what companies need to consider and ... event details »

SMi Group’s 13th Annual Conference - RNA Therapeutics 2022
London, UK – 02/09/2022
Bolstering the latest advances and opportunities in RNA-based medicine The RNA therapeutics industry has grown at an exponential rate in recent ... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA